Welcome to join us today for BICO’s Capital Markets Day! We are looking forward to see you all online later today at 1pm CEST. Register here: https://bico.com/cmd2024 #BICO #Strategy2.0 #CMD2024 #LabAutomation #Q&A #EMT #Maria Forss
Om oss
BICO is a leading provider of life science solutions and laboratory automation that enable more efficient development of new treatments with more specificity and less need for animal testing. The company uses bioconvergence as its operating system, combining advanced technologies with biology to streamline and automate workflows within the pharmaceutical and biopharma industries. With 32,000+ instruments installed in over 65 countries, BICO products and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,000 publications. Operating through three business areas – Bioprinting, Biosciences and Bioautomation – the BICO Group strives towards the long-term ambition of enabling the reduction the world’s organ shortage and speeding up drug development to create the future of life-saving treatments. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO.
- Webbplats
-
http://www.bico.com
Extern länk för BICO
- Bransch
- Forskning inom bioteknik
- Företagsstorlek
- 1 001–5 000 anställda
- Huvudkontor
- Kallebäck, Västra Götaland County
- Typ
- Publikt aktiebolag
- Specialistområden
- 3D Bioprinting, Bioprinting, Bioink, Biomedicine, Biotechnology, Biotech, Biomaterials, 3D printing, Stem cell research, Regenerative medicine, medicine, Medical research, R&D och Bioprinting research
Adresser
Anställda på BICO
Uppdateringar
-
BICO's Capital Markets Day is less than one week away! We look forward to welcoming you all on September 17 from 1-4 pm CEST for the launch of BICO’s updated strategy 2.0 and a deep dive into the field of lab automation. Register here: https://bico.com/cmd2024/ #BICO #Strategy2.0 #CMD2024 #LabAutomation
-
Ever wondered what lab automation is all about? Tune in on September 17 for BICO’s Capital Markets Day! Ryan Bernhardt, CEO at Biosero and Derrick Miyao, VP of Molecular Foundry at DeepCure will take you on a deep dive into the field of lab automation – exploring current trends, market development and customer insights. #BICO #Strategy2.0 #CMD2024 #LabAutomation
-
Exciting news from as BICO Company MatTek Life Sciences is expanding their global reach with a production facility in China through a strategic partnership with CellEx, a leading life science laboratory in China.
NEWS: We're thrilled to announce that MatTek has licensed its groundbreaking in vitro human tissue technology to CellEx, a leading life science laboratory in China. In alignment with our mission to expand access and to reliable 3D models worldwide, CellEx will produce our portfolio of organotypic human tissues using our proprietary technology. This strategic partnership marks a major milestone in expanding the global reach of our advanced tissue models, and enabling researchers in China to access superior, human-relevant solutions for research, pharmaceutical development, and safety assessments. Read more: https://bit.ly/4e9XkcO #betterscience #innovation
-
BICO 2.0, our updated strategy, will launch into the world on September 17! Tune in to the online portion of the Capital Markets Day and be among the first to learn more. Register here: https://lnkd.in/dFDR8eAN #BICO #Strategy2.0 #CMD2024 #LabAutomation
-
The BICO Group Q2 2024 interim report is live! Tune into the earnings call at 10 a.m. CEST presented by CEO and President Maria Forss and CFO Jacob Thordenberg with updates and comments of the development in the BICO Group. The report, link to earnings call, and presentations are available here: www.bico.com/investors
-
Welcome to BICO’s Capital Markets Day on September 17, 2024! Tune in for the launch of the Group’s updated strategy 2.0 and take a deep dive into the field of lab automation. Register via this link: https://lnkd.in/dFDR8eAN. #BICO #Strategy2.0 #CMD2024 #LabAutomation
-
Andreas Joersjö has been appointed as General Counsel, and we look forward to welcoming him to our Executive Management. Andréas will join BICO by mid-October at the latest. Read the press release: https://lnkd.in/dKmqNz6Z
-
BICO Group company MatTek Life Sciences just announced an exciting collaboration with Charles River Laboratories!
ICYMI: MatTek, in collaboration with Charles River Laboratories has been awarded a grant from the Foundation for Chemistry Research & Initiatives to advance non-animal research. The program will develop a new approach method (NAM) for inhalation toxicology. As leaders in the field of human tissue engineering, and the creators of EpiAirway, MatTek is uniquely qualified to lend its expertise to the project. “This partnership marks a pivotal moment where innovation and collaboration will lead us toward safer and more reliable outcomes for all," said MatTek CEO Alex Armento. Read more: https://bit.ly/3z8QLrK #betterscience #NAMs
-
Welcome Anders Fogelberg, BICO’s new Chief Commercial Officer Today we are thrilled to welcome Anders Fogelberg as our Chief Commercial Officer. Commercial excellence has been defined as one of our top strategic priorities and Anders will be pivotal in setting and driving the strategy towards that target, i.e., in scaling the BICO business, increasing the commercialization efforts of the portfolio and further explore opportunities for collaborations and partnerships. Join us in welcoming Anders to the BICO family! #welcometotheteam #CCO #newCCO #executivemanagement #BICO #commercialexcellence